Creating a quick test to find antibiotic resistance in bacteria
Development of a Rapid Antibiotic Susceptibility Test Capable of Detecting Heteroresistance
This study is working on a quick test to find a tricky type of antibiotic resistance in bacteria, which can help doctors choose the best treatment for patients with infections, making sure they get the right care faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10872221 on NIH RePORTER |
What this research studies
This research focuses on developing a rapid test that can detect a specific type of antibiotic resistance known as heteroresistance, where a small group of bacteria can resist treatment while the majority cannot. By identifying these resistant cells quickly, healthcare providers can choose the most effective antibiotics for patients, potentially preventing treatment failures. The approach aims to improve current testing methods that are often slow and unable to detect these rare resistant cells. This could lead to better outcomes for patients with infections caused by resistant bacteria.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from infections that are suspected to be caused by antibiotic-resistant bacteria.
Not a fit: Patients with infections caused by bacteria that are not resistant to antibiotics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the ability to treat infections caused by antibiotic-resistant bacteria, leading to better patient outcomes.
How similar studies have performed: Other research has shown promise in developing rapid diagnostic tests for antibiotic resistance, but this specific approach to detecting heteroresistance is relatively novel.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Yunker, Peter — Georgia Institute of Technology
- Study coordinator: Yunker, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.